The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Tuberculosis, Pulmonary

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Tuberculosis, Pulmonary


High impact information on Tuberculosis, Pulmonary


Chemical compound and disease context of Tuberculosis, Pulmonary


Biological context of Tuberculosis, Pulmonary


Anatomical context of Tuberculosis, Pulmonary


Gene context of Tuberculosis, Pulmonary


Analytical, diagnostic and therapeutic context of Tuberculosis, Pulmonary


  1. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Fitzgerald, D.W., Desvarieux, M., Severe, P., Joseph, P., Johnson, W.D., Pape, J.W. Lancet (2000) [Pubmed]
  2. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Castelo, A., Jardim, J.R., Goihman, S., Kalckman, A.S., Dalboni, M.A., da Silva, E.A., Haynes, R.B. Lancet (1989) [Pubmed]
  3. Autoantibodies to DEK oncoprotein in human inflammatory disease. Dong, X., Wang, J., Kabir, F.N., Shaw, M., Reed, A.M., Stein, L., Andrade, L.E., Trevisani, V.F., Miller, M.L., Fujii, T., Akizuki, M., Pachman, L.M., Satoh, M., Reeves, W.H. Arthritis Rheum. (2000) [Pubmed]
  4. Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. Alter-Koltunoff, M., Ehrlich, S., Dror, N., Azriel, A., Eilers, M., Hauser, H., Bowen, H., Barton, C.H., Tamura, T., Ozato, K., Levi, B.Z. J. Biol. Chem. (2003) [Pubmed]
  5. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Krumdieck, R., Shaw, D.R., Huang, S.T., Poon, M.C., Rustagi, P.K. Am. J. Med. (1991) [Pubmed]
  6. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. Perriëns, J.H., St Louis, M.E., Mukadi, Y.B., Brown, C., Prignot, J., Pouthier, F., Portaels, F., Willame, J.C., Mandala, J.K., Kaboto, M. N. Engl. J. Med. (1995) [Pubmed]
  7. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L., Horsburgh, C.R. N. Engl. J. Med. (1993) [Pubmed]
  8. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. Mahmoudi, A., Iseman, M.D. JAMA (1993) [Pubmed]
  9. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. Flores-Villanueva, P.O., Ruiz-Morales, J.A., Song, C.H., Flores, L.M., Jo, E.K., Montaño, M., Barnes, P.F., Selman, M., Granados, J. J. Exp. Med. (2005) [Pubmed]
  10. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. Nicholson, S., Bonecini-Almeida, M.d.a. .G., Lapa e Silva, J.R., Nathan, C., Xie, Q.W., Mumford, R., Weidner, J.R., Calaycay, J., Geng, J., Boechat, N., Linhares, C., Rom, W., Ho, J.L. J. Exp. Med. (1996) [Pubmed]
  11. Demonstration of tuberculostearic acid in sputum from patients with pulmonary tuberculosis by selected ion monitoring. Odham, G., Larsson, L., Mårdh, P.A. J. Clin. Invest. (1979) [Pubmed]
  12. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration. Okwera, A., Whalen, C., Byekwaso, F., Vjecha, M., Johnson, J., Huebner, R., Mugerwa, R., Ellner, J. Lancet (1994) [Pubmed]
  13. IgE class-specific suppressor T cells and factors in humans. Deguchi, H., Suemura, M., Ishizaka, A., Ozaki, Y., Kishimoto, S., Yamamura, Y., Kishimoto, T. J. Immunol. (1983) [Pubmed]
  14. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. Wang, J., Thorson, L., Stokes, R.W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., Xing, Z. J. Immunol. (2004) [Pubmed]
  15. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. Delgado, J.C., Baena, A., Thim, S., Goldfeld, A.E. J. Immunol. (2006) [Pubmed]
  16. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis. Ellard, G.A. Clin. Pharmacol. Ther. (1976) [Pubmed]
  17. Polymerase chain reaction--based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. Rajalingam, R., Mehra, N.K., Jain, R.C., Myneedu, V.P., Pande, J.N. J. Infect. Dis. (1996) [Pubmed]
  18. Some bacteriologic aspects of the epidemiology of pulmonary and extrapulmonary tuberculosis. Siddiqi, S.H., Stauffer, J.C., Ali, M.A., Middlebrook, G. Am. J. Epidemiol. (1976) [Pubmed]
  19. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Ellard, G.A., Gammon, P.T. British journal of clinical pharmacology. (1977) [Pubmed]
  20. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. Toossi, Z., Sedor, J.R., Lapurga, J.P., Ondash, R.J., Ellner, J.J. J. Clin. Invest. (1990) [Pubmed]
  21. Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. Gioia, C., Agrati, C., Casetti, R., Cairo, C., Borsellino, G., Battistini, L., Mancino, G., Goletti, D., Colizzi, V., Pucillo, L.P., Poccia, F. J. Immunol. (2002) [Pubmed]
  22. Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. Kuo, H.P., Wang, C.H., Huang, K.S., Lin, H.C., Yu, C.T., Liu, C.Y., Lu, L.C. Am. J. Respir. Crit. Care Med. (2000) [Pubmed]
  23. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Koguchi, Y., Kawakami, K., Uezu, K., Fukushima, K., Kon, S., Maeda, M., Nakamoto, A., Owan, I., Kuba, M., Kudeken, N., Azuma, M., Yara, S., Shinzato, T., Higa, F., Tateyama, M., Kadota, J., Mukae, H., Kohno, S., Uede, T., Saito, A. Am. J. Respir. Crit. Care Med. (2003) [Pubmed]
  24. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. Ainslie, G.M., Solomon, J.A., Bateman, E.D. Thorax (1992) [Pubmed]
  25. Transcriptional mechanisms regulating alveolar epithelial cell-specific CCL5 secretion in pulmonary tuberculosis. Wickremasinghe, M.I., Thomas, L.H., O'Kane, C.M., Uddin, J., Friedland, J.S. J. Biol. Chem. (2004) [Pubmed]
  26. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. Wallis, R.S., Kyambadde, P., Johnson, J.L., Horter, L., Kittle, R., Pohle, M., Ducar, C., Millard, M., Mayanja-Kizza, H., Whalen, C., Okwera, A. AIDS (2004) [Pubmed]
  27. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. Remus, N., El Baghdadi, J., Fieschi, C., Feinberg, J., Quintin, T., Chentoufi, M., Schurr, E., Benslimane, A., Casanova, J.L., Abel, L. J. Infect. Dis. (2004) [Pubmed]
  28. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Turner, J., D'Souza, C.D., Pearl, J.E., Marietta, P., Noel, M., Frank, A.A., Appelberg, R., Orme, I.M., Cooper, A.M. Am. J. Respir. Cell Mol. Biol. (2001) [Pubmed]
  29. HLA-A, -B, -C and -DR antigen profile in pulmonary tuberculosis in North India. Singh, S.P., Mehra, N.K., Dingley, H.B., Pande, J.N., Vaidya, M.C. Tissue Antigens (1983) [Pubmed]
  30. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. Santosuosso, M., Zhang, X., McCormick, S., Wang, J., Hitt, M., Xing, Z. J. Immunol. (2005) [Pubmed]
  31. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. Leemans, J.C., Juffermans, N.P., Florquin, S., van Rooijen, N., Vervoordeldonk, M.J., Verbon, A., van Deventer, S.J., van der Poll, T. J. Immunol. (2001) [Pubmed]
  32. Bill Dock and the location of pulmonary tuberculosis: how bed rest might have helped consumption. Murray, J.F. Am. J. Respir. Crit. Care Med. (2003) [Pubmed]
  33. Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Johnson, J.L., Ssekasanvu, E., Okwera, A., Mayanja, H., Hirsch, C.S., Nakibali, J.G., Jankus, D.D., Eisenach, K.D., Boom, W.H., Ellner, J.J., Mugerwa, R.D. Am. J. Respir. Crit. Care Med. (2003) [Pubmed]
  34. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis. Onsel, C., Sönmezoglu, K., Camsari, G., Atay, S., Cetin, S., Erdil, Y.T., Uslu, I., Uzun, A., Kanmaz, B., Sayman, H.B. J. Nucl. Med. (1996) [Pubmed]
WikiGenes - Universities